The Pros and Cons of Ozempic

The FDA does not like it when a company promotes and markets a drug that was used to treat a chronic disease for use by people that do not have that disease the FDA is not cool with that. There are potential regulatory concerns around the off label use of the drug. The American pediatric association recently included weight loss medication as part of a set of treatments that physicians should consider for kids with obesity so we may see a future where these obesity drugs are grouped with insulin on these essential medicines lists.